Exchange: NASDAQ·Updated 07:51 PM EDT
CODX logo

CODX Co-Diagnostics Inc

$0.7151
$0.0494
(6.46%)
Today
Closed $0.7151
$0.0448
(6.26%)
After Hours
EarningsNov 16
Mkt Cap$5.69M
Vol280,833.00

About CODX

Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests. The company was founded by Brent C. Satterfield and Dwight Howard Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.
43

Bearish Sentiment

How do you feel about CODX?

Millones
$CODX Overvalued and overweight. Less than $3MILLION in cash, added gross toxic terms liability loan with lien for entire business enterprise, next to zero revenue, price estimate lowered to $0.45. If quorum gets met today and measures approved, see y’all after the next reverse split. The SEC filings and fundamentals no longer match up with the artificial press releases. Fiscally and ethically irresponsible management/BoD. Best of luck.
2
5
Dany_italy
$CODX Oh my goodness, they are clinging by their fingernails from failure with my money, a lot of money put in here with good hopes. I hope a miracle happens with this herd of fools and incapables. Forgive my bad words, it's not like me, but now it's really too much. Maybe those who have been here for a short time will judge me as a bear or troll. I can assure you that I have been here for many years along with other friends in here and I have only seen the decline after the golden age of covid. So before judging this post, check from 2021 to today
1
6
tatanka9
$CODX Plague Detection!! lol- Leadership has failed every step along the way… except for rewarding themselves with massive compensation packages. F.U. Dwight!
4
Antiquarian
$CODX Seth Egan, Chief Commercialization Officer, will represent the Company at two global health events during the 81st Session of the United Nations General Assembly in New York City The Company will attend a reception, convened by UN Under-Secretary-General and UNOPS Executive Director Jorge Moreira da Silva, that brings together UNOPS leadership with executives and board members from across its hosted partnerships, including the Stop TB Partnership. Co-Dx will participate in this side event of the UN High-Level Meeting on Pandemic Prevention, Preparedness and Response ("PPPR"), convened by Indonesia's Ministry of Health, Japan's Ministry of Health, Labour and Welfare, and the Stop TB Partnership. The discussion will examine how lessons from the global tuberculosis response can help strengthen preparedness for future respiratory pandemics https://www.prnewswire.com/news-releases/co-diagnostics-to-participate-in-global-health-events-during-un-general-assembly-week-302887021.html
1
5
Dany_italy
$CODX How can they participate in events if they don't even have the money to cry? These are in total desperation and continue to spend money. This is fury. They are not capable. They had their stroke of luck under covid but now the reality is different. It takes a miracle with these elements imho
8
Millones
$CODX within five (5) Business Days from the funding of the Initial Loan, the Company shall file a new preliminary proxy statement in anticipation of the Stockholder’s Meeting which shall (i) include a full description of this Agreement and the other Transaction Documents, (ii) reflect that each Lender is voting the Lender’s Shares IN FAVOR of the proposals contained therein (other than any proposal seeking approval required under Nasdaq Listing Rule 5635(d) of the issuance of Conversion Shares upon conversion of the Notes or Make-Whole Shares), and (iii) seek Stockholder Approval of one or more reverse stock splits to be implemented by the Board of Directors within ranges of up to one share of Common Stock for each 750 shares of Common Stock then outstanding; and (iv) expressly include a proposal seeking the Stockholder Approval, with the Board of Directors recommending that the stockholders vote in favor of each all proposal submitted to the stockholders at the Stockholder Meeting
4
FilthyPeasant
$CODX Known Q4 catalysts include commercializing in North America (FDA 510k+CLIA waiver application pending) and commercializing in India (CDSCO approval of TB test pending). There's also intriguing opportunities for UN/WHO to 'recommend' the platform and help to market it, which seems likely in the future given that UN/WHO invited CoDx this summer to Bangkok to meet with heads of foreign governments and demonstrate their new platform. Also at that event, UN/WHO wanted to help heads of foreign governments in submitting grant funding proposals/requests to UN/WHO to purchase the platform. Billions of addressable market and it's trading for $0 EV ahead of approval because of historical sins of mgmt/delays in development timeline. glta
1
3
SmallPhish
$CODX This company is selling shares to pay around $1 million in salary and benefits to Dwight Egan and his 2 sons
7
FilthyPeasant
$CODX This UN event is tantalizing. Remember, when they went to Bangkok back in June at the invitation of the WHO, the point of the event was to demonstrate our technology to the Secretary of HHS-equivalents for various emerging world nations. The WHO was prepared to help Public Health governmental leaders at the event submit grant funding proposals to the WHO for purchasing these devices to expand diagnostics availability and pathogen-tracking in the corners of the world where it has yet to take hold (ie. India, SE Asia, Subsarahan Africa,etc.) Better days ahead in Q4 and they're on the verge of commercializing!
1
4
MediaAccount
$CODX what happens if someone or a some fund buys entire float? Just wondering. There are only 6.13M shares. Just hoping for a spike like we saw in June to $11.
7
FilthyPeasant
$CODX FDA 510k & CDSCO approvals of PCR PRO coming in Q4. Might see a formal recommendation from WHO for our platform, as well? exciting times ahead!
1
4
Millones
$CODX Maxim Group beating the war drums again. Pray for us in the next upcoming round of dilution and corporate restructuring.
6
MediaAccount
$CODX only hope is acquisition by a big company. Nice product line but no lifeline as they are almost out of cash to survive. Not sure if they could dilute more at a share price below a $1
6
SmallPhish
$CODX Good day of fundraising on volume of nearly 900,000 and no increase in share price. Ebola PRs are good for selling new shares
5
thatsolardude365
$CODX investors: an open class action alleges Co-Diagnostics hid collapsing demand for its Logix Smart COVID test. $6.5M settlement, about $0.36 a share before fees. Claims close Jan 6. Open Class Actions.
5
Nik_CA
$CODX is defying laws of physics. At onset of upcoming RS proposal, the SP should nose dive around $.50 BUT instead it’s holding well over $1.
5
mexx
$CODX Hello, my fellow stackers! Did I miss something during my long absence? 😄 What’s the latest on the approvals? Are we still staying above $1.X? And what happened to the “months, not years” Mormon prophecy? 😂 Greetings form down below.
5
skiphil
$CODX this partnering to do blood based detection is a joke. All the crap in blood is notoriously bad for a good PCR reaction. ReadyGo can get DNA out of a sample. CODX can do PCR on DNA. Sounds like a match made in heaven. But from what I have read, neither of these companies has the tech to clean up a blood based DNA sample well enough to get PCR to actually work on the result.
5
Tgaak
$CODX Hard to move ahead with R & D without $$. Time is also in play market is ripe with NewCo’s with cool tech for blood test diagnostics. For our much loved Codx $$ and time are running out = dilution event is coming, you can’t research or manufacture without both time and $$. Of course there is the miracle (this is Codx after all) a major grant or acquisition. There’s a lot of fun tech to look at here’s one - A study led by Tel Aviv University’s Department of Biomedical Engineering and Zimin Institute, JaxBio Technologies, Bnai Zion Medical Center and Sheba Medical Center published inNature Precision Oncology. The technology is designed to bypass sequencing. Researchers first extract cell-free DNA from a blood sample and label it with a light-emitting marker. The DNA is then attached to a specially developed DNA chip and scanned with an optical scanner. The resulting light patterns are analyzed to identify the biological fingerprint associated with lung cancer.
5
ldjozef
$CODX are the positive messages here from real people or bots? I can’t imagine people still supporting management after three reverse split. I’m happy I sold all my shares at 9 dollars. Now isn’t the moment to DCA, you will lose your money.
3

Advertisement|Remove ads.